For citations:
Tereshchenko S.N., Yarovaya E.B., Leontiev S.G., Yavelov I.S., Shakhnovich R.M., Erlikh A.D., Uskach T.M., Duplyakov D.V., Kutsenko V.A., Ivlev O.E., Soplenkova A.G., Semenov A.M., Semenov M.P., Ivanov S.V., Markin S.S. Non-immunogenic staphylokinase in patients with massive intermediate-high risk pulmonary embolism: protocol of the FORPE-2 multicenter, double-blind, randomized, placebo-controlled trial. Russian Journal of Cardiology. 2025;30(2):6291. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6291. EDN: UEUTUR
Email this article 